Challenges in quantitative analyses for volatile organic compounds bound to lipocalins.

In this communication, I describe the challenges in quantitative analyses for volatile organic compounds in mouse urine, which are primarily caused by the presence of the major urinary proteins, a lipocalin subfamily, that sequester volatile ligands. The analyses of volatile compounds in mouse urine have been performed since the late 1970s. However, none of them considered the binding interactions of the quantified compounds with the urinary proteins. Some volatile ligands are tightly bound to the proteins and may not be extracted completely by organic solvents. The amounts of volatile ligands measured by external standard calibration represent those of the unbound ligands in the headspace, not the total amounts in urine. Addition of internal standards displaces ligands bound to the proteins, resulting in a completely different volatile profile. Normalization of volatile compounds using relative peak area (or height) ratios may not be used in the conditions where displacement of ligands bound to the proteins occurs. Because of the unique chemical properties of mouse urine, I have not been able to find a good quantification method for the volatile compounds released from mouse urine. I hope that the identification of these issues will stimulate others to come up with novel approaches.